At what enterprise value was PETIQ acquired in 2024?

During the acquisition of PETIQ by BANSK GROUP in 2024, the transaction's Enterprise Value is estimated to be in the range of 1b - 4b USD.

What was the EV/EBITDA of PETIQ when it was acquired by BANSK GROUP?

The estimated EV/EBITDA multiple for PETIQ is in the range of 10x - 18x.

When was PETIQ acquired by BANSK GROUP?

PETIQ was acquired by BANSK GROUP in 2024.

What was the revenue of PETIQ at the time of the deal?

The revenue of PETIQ at the time of the deal is estimated to be in the range of 750M - 1.3b USD.

What was the EBITDA of PETIQ during the acquisition?

PETIQ's EBITDA is estimated to be in the range of 100M - 200M USD.

How is the data for the PETIQ acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the PETIQ deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.banskgroup.com/press-PetIQ-Announces-Successful-Completion-of-Acquisition-by-Bansk-Grou.html

← DATABASE

Home Database Healthcare & PharmaPETIQ

10/2024

PETIQ acquired by BANSK GROUP

UNITED STATES Life Sciences / Animal Health EV 1b - 4b USD

Context

Bansk Group completed the acquisition of 100% of PetIQ in an all-cash public-to-private transaction. PetIQ was delisted from Nasdaq upon closing and is now operated as a privately held company, with founder Cord Christensen continuing as CEO. The existing executive management team will continue to operate the business independently. The strategic rationale centres on accelerating PetIQ's mission of providing convenient and affordable pet healthcare, investing in marketing and innovation, and pursuing strategic bolt-on acquisitions — initiatives that Bansk believes are better executed outside the constraints of public market ownership.

PETIQ, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

PetIQ is a leading US-based pet medication, health and wellness company, operating across two complementary business segments: (1) a product division, which develops, manufactures, and distributes branded and third-party pet medications as well as health and wellness items through retail and e-commerce channels, with world-class manufacturing facilities located in Omaha (Nebraska), Springville (Utah), and Daytona Beach (Florida); and (2) a veterinary services division, which operates over 2,600 mobile community clinic locations and wellness centers hosted at retail partner locations across 39 US states, providing convenient and affordable access to veterinary care for pet owners.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
12/2024	UI INVESTISSEMENT	DIDACTIC	FRANCE	Medical Consumables
11/2024	NAXICAP PARTNERS	GLOBAL D	FRANCE	Implants & Prosthetics
10/2024	KKR / KREFELD	ANJAC BEAUTY & HEALTH	FRANCE	CDMO
10/2024	CLAYTON, DUBILIER & RICE (CD&R)	OPELLA	FRANCE	Generics / Labs
09/2024	AGILENT TECHNOLOGIES	BIOVECTRA	CANADA	CDMO
08/2024	NORDSON CORPORATION	ATRION CORPORATION	UNITED STATES	Diagnostic Equipment
08/2024	RECURSION PHARMACEUTICALS	EXSCIENTIA	UNITED KINGDOM	R&D Biotech
07/2024	ROCHE	LUMIRADX	UNITED KINGDOM	Diagnostic Equipment
05/2024	BRUKER	ELITECH GROUP	FRANCE	Diagnostic Equipment
05/2024	GTCR	SURMODICS	UNITED STATES	Medical Devices

REFERENCES

Valuation range: EV 1b - 4b USD

Revenue range: 750M - 1.3b USD

EBITDA range: 100M - 200M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PETIQ by BANSK GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: bansk group